Founded in 1984, CryoLife is among the leaders in the processing and distribution of implantable living human tissues for use in cardiovascular and vascular surgeries. CryoLife products are used in surgeries throughout the United States and Canada. The company s BioGlue surgical adhesive is approved by the Food and Drug Administration as an adjunct to sutures and stapes. The glue is used for adult patients in open surgical repair of large vessels and is CE-marked in the European communication. It is approved in Canada for use in soft tissue repair. BioGlue is approved in Australia for use in vascular and pulmonary sealing and repair. CryoLife is based in Kennesaw, Ga. It trades on the New York Stock Exchange under the symbol CRY.